Hotbed/Location

Found 479,851 articles

• SCIEX Presenting New Applications at Global CESI-MS Symposium 2018

  9/21/2018

  Innovations in ultra low-flow separation and accurate mass analysis expands into proteomics, metabolomics, food and environmental monitoring

• Cannabics Pharmaceuticals to Present Results of Clinical Trial at International Medical Cannabis Conference

  9/21/2018

  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on Cancer and its side effects, today announced that Dr. Gil Bar-Sela is scheduled to present his findings at the 3rd International Medical Cannabis Conference

• LUNGevity to Present New Data from Its Patient Preference Study at 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity's Project Transform captures what patients are seeking from their treatments

• Puration Announces LOI to Spinoff Cannabis Cultivation Business and Issue Stock Dividend to Shareholders

  9/21/2018

  Puration, Inc. (USOTC: PURA) ("PURA") today announced executing a letter of intent ("LOI") to spinoff its cannabis cultivation business. The prospective "spinoff" will be affected by selling the cannabis cultivation business to a target publicly traded holding company

• LUNGevity to Present Two Studies from Its Patient FoRCe Research Center at the 2018 World Conference on Lung Cancer

  9/21/2018

  LUNGevity to present information about Attitudes Toward Re-Biopsy and a Patient Education Audit

• LUNGevity to Present Data from Study on Patient Empowerment at 2018 World Conference on Lung Cancer

  9/21/2018

  Study illuminates obstacles to patients receiving education about their disease

• JOOL Health and the University of Delaware team up to improve employee well-being

  9/21/2018

  JOOL Health today announced a new partnership to bring JOOL's groundbreaking solution to the faculty and staff of the University of Delaware. JOOL is a digital personal life coach that improves overall employee well-being and organizational performance, by combining the science of purpose with advanced data analytics.

• Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018

  9/21/2018

  Global Cord Blood Corporation today announced that the Company will hold its 2018 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2018 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2018).

• Phosphorus Launches Expanded Dyslipidemia Test with Pharmacogenetic Indications and Polygenic Risk Score

  9/21/2018

  Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced today, at the National Lipid Association Fall Clinical Lipid Update meeting, the launch of an expanded genetic test for inherited dyslipidemias.

• Susan G. Komen® Recognizes Renowned Investigators as 2018 Recipients of Brinker Awards for Scientific Distinction

  9/21/2018

  Two widely respected and prolific breast cancer investigators today join the ranks of an esteemed group of scientists as recipients of this year’s Brinker Awards – the highest scientific honor awarded by Susan G. Komen®, the world’s leading breast cancer organization.

• Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market

  9/21/2018

  Biocept, Inc. today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $2.5 million of its common stock

• Population Health Initiative To Pioneer Sustainable Community Influenza Vaccination Models For Underserved, Older Adults

  9/21/2018

  Sustainable Healthy Communities (SHC), a wholly owned subsidiary of the National Minority Quality Forum (NMQF), today announced a new population health initiative aimed at improving patient outcomes in underserved communities.

• Agenus Closes $15 Million Partial Royalty Monetization With XOMA

  9/21/2018

  Agenus Inc. cancer vaccines, and adoptive cell therapies1, today announced the closing of its non-dilutive royalty transaction with XOMA Corporation

• Thomas Rapisardo, M.D., Receives First Annual Healthcare Hero Award For Distinguished VA Service To Veterans

  9/21/2018

  Thomas Rapisardo, M.D., today received the first annual Healthcare Hero Award from The Independence Fund for his exemplary service and dedication to America's wounded, ill, and injured Veterans.

• Multiple Surgeon Presentations to Showcase Glaukos Products at 2018 European Society of Cataract and Refractive Surgeons Congress

  9/21/2018

  Glaukos Corporation announced today that its products will be included in various physician presentations at the 36th Congress of the European Society of Cataract and Refractive Surgeons

• SpringCM, a DocuSign Company, Announces #DreamWithJames Social Media Campaign to Raise Awareness for Curing Childhood Disease

  9/21/2018

  pringCM, a DocuSign company, today announced that it has launched a social media campaign to raise money for New Genes, a not-for-profit organization dedicated to gene replacement therapy to address terminal childhood diseases.

• uBiome Announces Expansion into Microbiome-Based Therapeutics, Appoints Pharmaceutical Veteran Joseph Jimenez to Board of Directors

  9/21/2018

  uBiome Opens Therapeutics Headquarters in Cambridge, Massachusetts to Support Drug Discovery and Development

• Mylan Launches Authorized Generic of Ampyra® Tablets

  9/21/2018

  Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Dalfampridine Extended-Release Tablets, 10 mg, the authorized generic version of Acorda's Ampyra®, which is indicated to improve walking in adult patients with multiple sclerosis.

• Catching the Future of Life Sciences and the Opportunities for Canada

  9/21/2018

  In celebration of Global Biotech Week, CDRD and BIOTECanada invite you to a thought-provoking evening to experience changes in life sciences and biotechnology that are unfolding today.

• uBiome Announces $83 Million Series C Financing

  9/21/2018

  uBiome Will Expand World’s Largest Human Microbiome Database and Advance Product Portfolio, Including Drug Discovery & Development